Teva And Cephalon's Marketing Ignored Plea Deal, Judge Told

By Bonnie Eslinger · May 26, 2022, 11:31 PM EDT

Teva and Cephalon improperly peddled their painkiller Fentora even after Cephalon reached a 2008 plea agreement to resolve criminal claims it marketed a different opioid for unapproved uses, San Francisco's lawyer...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Case Title

City and County of San Francisco et al v. Purdue Pharma L.P. et al

Case Number

3:18-cv-07591

Court

California Northern

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

December 18, 2018

Recent Articles By Bonnie

June 28, 2024
Texas Justices Back Ban On Gender Affirming Care For Minors
June 28, 2024
Jury Convicts Seattle Doctor In NBA Health Fraud Case
May 17, 2024
Pfizer Unit Wins $107.5M Patent Verdict Against AstraZeneca
March 22, 2024
Expert's Sanctions Off Limits In SEC's 'Shadow Trading' Trial
March 11, 2024
Acadia Investors Get Class Cert. In Suit Over Parkinson's Drug
March 08, 2024
Trump 'An Existential Threat' To Rule Of Law, Attys Warn
January 22, 2024
HIV Drug Wholesalers' Attys Get $75M In Gilead Antitrust Case
January 08, 2024
Teva, Israeli Investors End Investor Suit Over Opioid Scandal
January 05, 2024
9th Circ. Won't Rethink FCA Disclosure Ruling Against Valeant
January 03, 2024
ACTS Retirement Data Breach Suit Settlement Gets Initial OK

Teva And Cephalon's Marketing Ignored Plea Deal, Judge Told

Related Sections

Case Information

Case Title

Case Number

Court

Nature of Suit

Date Filed

Case Title

Case Number

Court

Nature of Suit

Date Filed

Recent Articles By Bonnie